Bookmark
Forward
Explore Literature Results
QuickView for SLCO2B1;jsessionid=902667E0D2FD96B250C8928B648BD13E;jsessionid=B49BAB0473496728C79E12E098B96E7D;jsessionid=89E7B74033B70C4D6478048ED23EC998;jsessionid=D2714BFBE106442621EB588AEEE01559;jsessionid=5BB0BF3128FAD86A87EA710161555500;jsessionid=13153A14AAD397FC71A9B80AE446F533;jsessionid=E19941F602B6B5AC43C586A538122DBC;jsessionid=31FB6C2602D53502D98F3C6834FFA97E;jsessionid=7EA5BED471E86847C5322020F3A4EBEA;jsessionid=454C5DFBCF8A5D82DFD6A552ED4F59DE (gene)
Most Correlated Tissues
Task java.util.concurrent.FutureTask@5334e58 rejected from java.util.concurrent.ThreadPoolExecutor@527b86ce[Running, pool size = 100, active threads = 98, queued tasks = 0, completed tasks = 19240350]
Explore Body Atlas Results
Most Relevant Literature
- Influence of Slco2b1-knockout and SLCO2B1-humanization on coproporphyrin I and III levels in rats.
- Metabolic-scale gene activation screens identify SLCO2B1 as a heme transporter that enhances cellula…
- Role of Oatp2b1 in Drug Absorption and Drug-Drug Interactions.
- Risk of Developing Hepatocellular Carcinoma following Depressive Disorder Based on the Expression Le…
- Uremic Toxin Indoxyl Sulfate Promotes Proinflammatory Macrophage Activation Via the Interplay of OAT…
Most Relevant Clinical Trials
There were no clinical trials for SLCO2B1;jsessionid=902667E0D2FD96B250C8928B648BD13E;jsessionid=B49BAB0473496728C79E12E098B96E7D;jsessionid=89E7B74033B70C4D6478048ED23EC998;jsessionid=D2714BFBE106442621EB588AEEE01559;jsessionid=5BB0BF3128FAD86A87EA710161555500;jsessionid=13153A14AAD397FC71A9B80AE446F533;jsessionid=E19941F602B6B5AC43C586A538122DBC;jsessionid=31FB6C2602D53502D98F3C6834FFA97E;jsessionid=7EA5BED471E86847C5322020F3A4EBEA;jsessionid=454C5DFBCF8A5D82DFD6A552ED4F59DE
Explore Clinical Trials Results
